India should focus on getting vaccine right instead of jabbing at glory
04 January 2021 - 11:58
Like many things in India nowadays, the science of vaccine approval has also run into the politics of chest-thumping nationalism.
Alongside authorising Covishield, the Covid-19 protection developed by Oxford University and AstraZeneca and manufactured by the Serum Institute of India, the country’s drugs regulator on Sunday gave a go-ahead to an indigenous vaccine for which critical phase 3 trial data isn’t yet available...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.